Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Conditions: Crohn Disease; Child, Only; Biologic; Inadequate Intervention: Drug: Infliximab Sponsor: Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2022 Category: Research Source Type: clinical trials
Prognosis in UC After First Biological
Condition: Ulcerative Colitis Intervention: Biological: infliximab, adalimumab, golimumab, vedolizumab, ustekinumab Sponsor: Tampere University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2022 Category: Research Source Type: clinical trials